Quantum Laboratories Memory Disorder Center
Deerfield Beach, Florida, United States
Medical laboratory in Pompano Beach, Florida
50 E Sample Rd # 201, Pompano Beach, FL 33064
About Quantum Laboratories Memory Disorder Center
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
GliaCure, Inc.
1
Novartis
1
Clinical Trials at Quantum Laboratories Memory Disorder Center
During the past decade, Quantum Laboratories Memory Disorder Center conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Effects of Rivastigmine Patch on Activities of Daily Living and Cognition in Patients With Severe Dementia of the Alzheimer's Type (ACTION) (Study Protocol CENA713DUS44, NCT00948766) and a 24 Week Open-label Extension to Study CENA713DUS44
2009-07-01
2012-06-01
Completed
716
Study Evaluating Safety, Tolerability, and PK of Multiple Ascending Doses of GC021109 in Subjects With Mild to Moderate Alzheimer's Disease
2015-02-01
2015-10-01
Completed
39
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Quantum Laboratories Memory Disorder Center
According to Clinical.Site data, the most researched conditions in "Quantum Laboratories Memory Disorder Center" are
"Alzheimer's Disease" (2 trials). Many other conditions were trialed in "Quantum Laboratories Memory Disorder Center" in a lesser frequency.
Clinical Trials Intervention Types at Quantum Laboratories Memory Disorder Center
Most popular intervention types in "Quantum Laboratories Memory Disorder Center" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials), "GC021109" (1 trials), "Rivastigmine 13.3 mg/24 h (15 cm^2)" (1 trials), "Rivastigmine 4.6 mg/24 h (5 cm^2)" (1 trials) and "Rivastigmine 9.5 mg/24 h (10 cm^2)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Quantum Laboratories Memory Disorder Center
The vast majority of trials in "Quantum Laboratories Memory Disorder Center" are
2 trials for "All" genders.
Clinical Trials Status at Quantum Laboratories Memory Disorder Center
Currently, there are NaN active trials in "Quantum Laboratories Memory Disorder Center".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Quantum Laboratories Memory Disorder Center,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Quantum Laboratories Memory Disorder Center, 1 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".